New HFpEF recommendations | Private equity-backed cardiology groups merge | COVID-19 & heart rhythm issues

HFpEF now accounts for a majority of heart failure cases, highlighting the importance of ensuring both primary care providers and dedicated heart teams know as much about this topic as possible. 

Cardiovascular Associates of America and Novocardia have joined forces to form what they describe as the "strongest cardiovascular network in America."

Patients with severe COVID-19 cases that required ventilation were 16 times more likely to develop ventricular tachycardia within six months, researchers found. 

After high-risk medical devices go through the initial FDA approval process, it is relatively easy for manufacturers to get updates to those devices approved. New evidence suggests that this policy could be leading to more recalls, especially among cardiovascular devices.  

HeartPlace, a Dallas-based cardiology practice with more than 20 locations, is the newest member of the USHV family. 

Researchers evaluated data from more than 200 patients who underwent redo TAVR, noting that women and patients with a higher BMI faced a higher risk of coronary flow compromise.

“Leadless pacemaker technology is the wave of the future,” one researcher said. “This is an excellent technology that may be offered to a wider pediatric population."

ASNC President Mouaz Al-Mallah, MD, and ASNC President-elect Larry Phillips, MD, discussed some of the key trends in cardiac molecular imaging at ACC.23. 

The American Roentgen Ray Society is seeking $665,523 in damages along with any related attorneys’ fees, according to the complaint.

The recall includes more than 1,500 devices distributed to customers from October 2021 to January 2023.